Page last updated: 2024-09-05

eslicarbazepine acetate and Cognitive Dysfunction

eslicarbazepine acetate has been researched along with Cognitive Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andermann, E; Ben-Menachem, E; Benbadis, SR; Biraben, A; Biton, V; Blum, D; Carreño, M; Cheng, H; Gama, H; Rocha, F; Shah, AK; Shneker, B; Trinka, E	1

Reviews

1 review(s) available for eslicarbazepine acetate and Cognitive Dysfunction

Article	Year
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures. Epilepsy & behavior : E&B, 2018, Volume: 82 Topics: Adolescent; Adult; Aged; Anticonvulsants; Clinical Trials, Phase III as Topic; Cognitive Dysfunction; Depression; Depressive Disorder; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Seizures; Treatment Outcome	2018

Article

Year

Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.

Epilepsy & behavior : E&B, 2018, Volume: 82

Topics: Adolescent; Adult; Aged; Anticonvulsants; Clinical Trials, Phase III as Topic; Cognitive Dysfunction; Depression; Depressive Disorder; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Seizures; Treatment Outcome

2018